Pharmacist’s Corner: What You Need to Know About Hydroxychloroquine

By Marina Entin, Rph, BS Hydroxychloroquine is in a class of drugs called antimalarials. It is used primarily in the prevention and treatment of malaria. It works by killing the organisms that cause malaria. Hydroxychloroquine may work in rheumatoid arthritis and systemic lupus erythematous by decreasing the activity of the immune system. According to the most recent New England JournalContinue reading “Pharmacist’s Corner: What You Need to Know About Hydroxychloroquine”

A Nation’s Cry & A Moment for Greater Diversity in Clinical Trials

Since 2020 began, the U.S. Food & Drug Administration (FDA) has approved at least twenty new drugs for use by American consumers, but over 90% of those drugs were tested on a subject population that lacked sufficient race and ethnic diversity to determine if the drug would be safe and effective for everyone.  With aContinue reading “A Nation’s Cry & A Moment for Greater Diversity in Clinical Trials”

Staying Medication Safe During the COVID-19 Pandemic Response

During this time of nationwide concern and response to address the COVID-19 pandemic, Safest Drug is urging the general public to be even more cautious about how to lower their risk of experiencing a serious adverse drug reaction that may result in a temporary or permanent medication harm, including what to do if you experience aContinue reading “Staying Medication Safe During the COVID-19 Pandemic Response”

PRESS RELEASE: Safest Drug Launches “Ask, Read, Report” Campaign

CHAPEL HILL, N.C. – Safest Drug is launching its first education campaign, a medication safety initiative called “Ask, Read, Report”.  The purpose of the campaign is to create safer healthcare consumers of pharmaceutical medications who are more informed about medication safety risks and are better prepared to report their adverse drug reactions.  The “Ask, Read, Report”Continue reading “PRESS RELEASE: Safest Drug Launches “Ask, Read, Report” Campaign”

Popular Antidepressant Among Pharmaceutical Drugs With Labeling Updates

Cymbalta, a popular antidepressant medication is among the more than 90 entries of drugs with safety-related labeling changes released this month, so far, by the FDA. FDA-approved in 2004, Cymbalta (a duloxetine delayed-release capsule) is indicated to treat Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathic Pain, Fibromyalgia and Chronic Musculoskeletal Pain. The drugContinue reading “Popular Antidepressant Among Pharmaceutical Drugs With Labeling Updates”

FDA Releases New Black Box Warning Updates on 13 Drugs

Last month, a list of 13 medications received new black boxed warning changes, according to the FDA’s Drug Safety-Related Labeling Changes page.   Since the 1970s, the FDA has regularly issued these “boxed warnings” (also called “black box warnings” due to how the warnings appear in certain labeling documentation) as a means to communicate strong advisoryContinue reading “FDA Releases New Black Box Warning Updates on 13 Drugs”

PRESS RELEASE: Safest Drug Announces Nationwide Policy Agenda

CHAPEL HILL, N.C. – Safest Drug, a nonprofit founded earlier this year to alleviate and prevent medication-related illness, disability and death in the United States, announced their policy agenda today.  Their plans to advocate for over 300 million people living in America are a first for the startup and was built with one group inContinue reading “PRESS RELEASE: Safest Drug Announces Nationwide Policy Agenda”

Routine Updates to Drug Labeling Still Cause For Concern

What some consumers may not realize is that the FDA releases approved safety-related labeling changes through their website on a regular basis. As a matter of fact, this month there were changes to over 50 different medications. It should go without saying, but updates to our drug labels are incredibly important. These updates provide healthcareContinue reading “Routine Updates to Drug Labeling Still Cause For Concern”

Finasteride Approval Evidence of a Clinical Research Problem in U.S.

Michael was a 27-year-old with a happy life in New York City and a bright future as a book editor in front of him. That all changed after taking a seemingly harmless prescription drug known by the brand name Propecia.  Propecia, also known in its generic form as finasteride, is a prescription medication he took underContinue reading “Finasteride Approval Evidence of a Clinical Research Problem in U.S.”